The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALTO NEUROSCIENCE INC COM SHS 02157Q109   10,250,392 667,778 SH   DFND   0 667,778 0
CARIBOU BIOSCIENCES INC COM 142038108   2,436,704 474,067 SH   DFND   0 474,067 0
KORRO BIO INC COM 500946108   24,914,790 276,831 SH   DFND   0 276,831 0
LENZ THERAPEUTICS INC COM 52635N103   22,726,380 1,017,751 SH   DFND   0 1,017,751 0
OMEGA THERAPEUTICS INC COMMON STOCK 68217N105   1,288,235 352,941 SH   DFND   0 352,941 0
PRAXIS PRECISION MEDICINES I COM NEW 74006W207   4,023,232 65,933 SH   DFND   0 65,933 0
TURNSTONE BIOLOGICS CORP COM 90042W100   1,440,950 549,981 SH   DFND   0 549,981 0